difference between zepbound and compounded tirzepatide Joi + Blokes 2026: Is It FDA-Approved or - Why the Pricing Most Consumers See May Not Be What They Actually Pay Transition to Branded Weight Loss

December 17, 2024 Novo Nordisks Ozempic is under examination after two Danish studies found a potential connection between the drug and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition that can lead to vision loss from reduced blood flow to the optic nerve

& Ou, C

Rob Berberian offers in-person consultations in Newport Beach and virtual consultations for patients throughout Orange County, Los Angeles, California, and the rest of the USA

Multiple companies have announced or disclosed internal shifts away from small-molecule oncology programs toward biologics and cell and gene therapies

Retatrutide has shown approximately 24% body-weight reduction in phase 2 obesity research at the highest studied dose over 48 weeks [8], while REDEFINE 1 Phase 3 data reported 22.7% mean weight reduction with CagriSema at week 68 [3]